系统综述与荟萃分析:使用世界内镜组织命名法评估结肠镜检查后结直肠癌的患病率
该系统综述与荟萃分析采用世界内镜组织(WEO)标准化方法,评估结肠镜检查后结直肠癌(PCCRC)的患病率。近端PCCRC患病率高于远端(9.7% vs 5.4%),但研究间异质性高,随时间趋势不一致。
要点
- 采用WEO精确方法的欧洲研究合并3年PCCRC患病率为8.2%。
- 近端PCCRC患病率(9.7%)高于远端(5.4%)。
- 研究间异质性高,PCCRC随时间变化趋势不一致。
核心结论
- 采用WEO精确方法的四项欧洲研究合并3年PCCRC患病率为8.2%(95%CI=6.9%-9.4%)。
- 尽管使用WEO标准化方法,研究间仍存在显著异质性,人群间比较仍具挑战。
研究设计与样本
- 系统综述与荟萃分析,更新先前系统综述,检索Ovid MEDLINE和EMBASE数据库(2013年1月1日至2021年1月31日)。
主要发现
- 四项欧洲研究采用WEO精确方法计算的合并3年PCCRC患病率为8.2%(95%CI=6.9%-9.4%,I2=98.2%)。
- 近端PCCRC患病率为9.7%(95%CI=7.0%-12.4%),远端为5.4%(95%CI=2.9%-7.8%),I2=99.2%。
- 七项研究报告PCCRC率随时间变化,趋势不一致:四项下降、一项上升、两项不变。
- 研究间异质性高。
关键数值与推荐
- PCCRC 3年患病率合并值为8.2%(95%CI=6.9%-9.4%),基于四项欧洲研究采用WEO精确方法。
- 近端PCCRC患病率9.7%(95%CI=7.0%-12.4%),远端5.4%(95%CI=2.9%-7.8%)。
临床怎么用
- PCCRC可作为结肠镜检查质量保证的性能指标,但需注意研究间异质性。
- 采用WEO标准化方法有助于统一PCCRC的定义和计算,但人群间比较仍需谨慎。
局限性
- 研究间异质性高(I2=98.2%),可能影响合并结果的解释。
- 仅四项欧洲研究采用WEO精确方法,全球代表性有限。
- 需要更多研究以更好地理解全球PCCRC负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Post-colonoscopy colorectal cancers (PCCRCs) have been proposed as a performance metric for colonoscopy quality assurance programs. Previously, there was no standardised terminology or reporting methods. In 2018, the World Endoscopy Organization (WEO) advised standardised definitions and prevalence calculation methodology. AIMS: To assess PCCRC burden using WEO standardised methods, to explore causes of heterogeneity, and to review changes in prevalence over time METHODS: We updated a prior systematic review by searching Ovid MEDLINE and EMBASE databases from 1 January 2013 to 31 January 2021 to identify population-based studies (or multicentre studies representative of the local population) reporting PCCRC prevalence (PROSPERO [CRD42020183796]). Two authors independently determined study eligibility, assessed quality, and extracted data. We estimated the PCCRC 3-year prevalence using WEO-recommended methodologies and investigated between-study sources of heterogeneity. We examined changes in prevalence over time. RESULTS: Fifteen studies reporting on 25 872 PCCRC cases met eligibility criteria. Pooled PCCRC 3 year prevalence was 8.2% (95% CI = 6.9%-9.4%, I2 = 98.2%) across four European studies using WEO precise methodology. Proximal PCCRC prevalence was greater than distal (9.7% [95% CI = 7.0%-12.4%] vs 5.4% [95% CI = 2.9%-7.8%], I2 = 99.2%). Seven studies reporting PCCRC rates over time showed no consistent trend: four showed a decrease, one an increase and two were unchanged. Between-study heterogeneity was high. CONCLUSIONS: Pooled 3-year PCCRC prevalence was 8.2% (95% CI = 6.9%-9.4%). Despite WEO standardised methodology to define and calculate PCCRC rates, there was significant heterogeneity among studies. Comparing rates between populations remains challenging and additional studies are needed to better understand the global PCCRC burden to inform quality assurance programs.
引用
- Kang JH, Evans N, Singh S, et al. Systematic review with meta-analysis: the prevalence of post-colonoscopy colorectal cancers using the World Endoscopy Organization nomenclature. Aliment Pharmacol Ther. 2021. PMID: 34587323. doi:10.1111/apt.16622
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。